Eve Barys/LinkedIn
May 7, 2026, 15:34
Eve Barys: What’s New – Thrombosis in Immune Thrombocytopenia
Eve Barys, Sr. Strategic Account Executive at Wolters Kluwer Health, shared a post on LinkedIn:
“Immune thrombocytopenia (ITP) is generally associated with bleeding, but individuals with ITP can also develop thrombosis.
A study of ITP documented venous thrombosis in about 4 percent of patients.
Features associated with thrombosis included older age, prior thrombosis, secondary ITP, and use of a thrombopoietin receptor agonist.
Management with anticoagulation is appropriate, and some individuals may require more intensive ITP therapies to raise the platelet count and allow for full anticoagulation.”
Stay updated with Hemostasis Today.
-
May 7, 2026, 15:33Tareq Abadl: The Hidden Danger in a Blood Bag – When a Unit Looks ‘Wrong’
-
May 7, 2026, 15:23Ahmed Nasreldein: Pleasure to Reconnect with Friends and Colleagues from Around the World at ESOC 2026
-
May 7, 2026, 15:14Meta-analysis of RCTs – International Journal of Stroke
-
May 7, 2026, 15:12Rob Maloney: Camp and the Power of Possibility for Children with Bleeding Disorders
-
May 7, 2026, 15:08Joseph R. Shaw: Individualized Risk-Adapted Perioperative Anticoagulation Management for APS Is Feasible and Safe
-
May 7, 2026, 15:00William Aird։ Not Every Clot Is DOAC Failure
-
May 7, 2026, 15:00What Hematologists Should Know About Pregnancy-Onset TTP – ASH Education
-
May 7, 2026, 14:54Matthias König: Developing an Open Whole-Body PBPK/PD Digital Twin of Apixaban
-
May 7, 2026, 14:48Honoring Compassion, Leadership, and Excellence in Hemophilia Care on National Nurses Day – Hemophilia Alliance